Login Join for free
Popular Searches
Popular news More >
SEARCHING....
no results found
  • Real Time Chart Real Time Chart
  • Stock Profile Stock Profile

  • Financials As Reported

    • accession Number 0001703057-23-000008
    • accumulated Depreciation Depletion And Amortization Property Plant And Equipment 21,333,000
    • accumulated Other Comprehensive Income Loss Net Of Tax --2,021,000
    • allocated Share Based Compensation Expense 15,474,000
    • amendment Flag false
    • assets 1,497,919,000
    • assets Current 940,653,000
    • assets Noncurrent 557,266,000
    • cash And Cash Equivalents At Carrying Value 193,017,000
    • cash Cash Equivalents And Marketable Securities 796,495,000
    • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 218,017,000
    • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --194,343,000
    • cik 1,703,057
    • city Area Code 604
    • common Stock Shares Issued 286,851,595
    • common Stock Shares Outstanding 286,851,595
    • comprehensive Income Net Of Tax --40,740,000
    • contract With Customer Liability 37,223,000
    • contract With Customer Liability Current 11,807,000
    • contract With Customer Liability Revenue Recognized 4,800,000
    • current Fiscal Year End Date --12-31
    • date Filed 2023-05-04
    • depreciation 2,900,000
    • document Fiscal Period Focus Q1
    • document Fiscal Year Focus 2,023
    • document Period End Date 2023-03-31
    • document Transition Report false
    • document Type 10-Q
    • earnings Per Share Basic -0.14
    • earnings Per Share Diluted -0.14
    • entity Address Address Line 1 2215 Yukon Street
    • entity Address City Or Town Vancouver
    • entity Address Postal Zip Code V5Y 0A1
    • entity Address State Or Province BC
    • entity Central Index Key 1,703,057
    • entity Current Reporting Status Yes
    • entity Emerging Growth Company false
    • entity File Number 001-39781
    • entity Filer Category Large Accelerated Filer
    • entity Incorporation State Country Code A1
    • entity Interactive Data Current Yes
    • entity Name AbCellera Biologics Inc.
    • entity Registrant Name AbCellera Biologics Inc.
    • entity Shell Company false
    • entity Small Business false
    • income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest --48,148,000
    • income Tax Expense Benefit --8,038,000
    • increase Decrease In Other Operating Assets 6,063,000
    • irs Number 0
    • liabilities 289,419,000
    • liabilities And Stockholders Equity 1,497,919,000
    • liabilities Current 89,591,000
    • liabilities Noncurrent 199,828,000
    • local Phone Number 559-9005
    • net Cash Provided By Used In Financing Activities --458,000
    • net Cash Provided By Used In Investing Activities --149,609,000
    • net Cash Provided By Used In Operating Activities --44,063,000
    • net Income Loss --40,110,000
    • nonoperating Income Expense 16,726,000
    • operating Expenses 77,066,000
    • operating Income Loss --64,874,000
    • operating Lease Liability Current 5,868,000
    • operating Lease Liability Noncurrent 77,265,000
    • other Assets Current 99,155,000
    • other Assets Noncurrent 89,845,000
    • other Liabilities Noncurrent 2,962,000
    • other Noncash Income Expense 3,634,000
    • other Nonoperating Income Expense 3,593,000
    • payments To Acquire Property Plant And Equipment 14,984,000
    • period End 1,680,220,800,000
    • period Start 1,672,531,200,000
    • property Plant And Equipment Gross 254,520,000
    • property Plant And Equipment Net 233,187,000
    • report Link https://www.sec.gov/Archives/edgar/data/1703057/000170305723000008/abcl-20230331_htm.xml
    • research And Development Expense 52,647,000
    • retained Earnings Accumulated Deficit 386,075,000
    • revenue From Contract With Customer Excluding Assessed Tax 12,192,000
    • share Based Compensation 15,474,000
    • stockholders Equity 1,208,500,000
    • trading Symbol ABCL
    • update 1970-01-01
    • weighted Average Number Of Diluted Shares Outstanding 287,767,136
    • weighted Average Number Of Shares Outstanding Basic 287,767,136
    • id REPORTED_FINANCIALS
    • key ABCL
    • subkey 10-Q
    • date 2023-05-04
    • updated 2023-05-05
  • Symbol Info Symbol Info
  • Symbol Over View Symbol Over View
  • Technical Analysis Technical Analysis

ABCL stock fundamentals - financials as reported

Financials As Reported

  • accession Number 0001703057-23-000008
  • accumulated Depreciation Depletion And Amortization Property Plant And Equipment 21,333,000
  • accumulated Other Comprehensive Income Loss Net Of Tax --2,021,000
  • allocated Share Based Compensation Expense 15,474,000
  • amendment Flag false
  • assets 1,497,919,000
  • assets Current 940,653,000
  • assets Noncurrent 557,266,000
  • cash And Cash Equivalents At Carrying Value 193,017,000
  • cash Cash Equivalents And Marketable Securities 796,495,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 218,017,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --194,343,000
  • cik 1,703,057
  • city Area Code 604
  • common Stock Shares Issued 286,851,595
  • common Stock Shares Outstanding 286,851,595
  • comprehensive Income Net Of Tax --40,740,000
  • contract With Customer Liability 37,223,000
  • contract With Customer Liability Current 11,807,000
  • contract With Customer Liability Revenue Recognized 4,800,000
  • current Fiscal Year End Date --12-31
  • date Filed 2023-05-04
  • depreciation 2,900,000
  • document Fiscal Period Focus Q1
  • document Fiscal Year Focus 2,023
  • document Period End Date 2023-03-31
  • document Transition Report false
  • document Type 10-Q
  • earnings Per Share Basic -0.14
  • earnings Per Share Diluted -0.14
  • entity Address Address Line 1 2215 Yukon Street
  • entity Address City Or Town Vancouver
  • entity Address Postal Zip Code V5Y 0A1
  • entity Address State Or Province BC
  • entity Central Index Key 1,703,057
  • entity Current Reporting Status Yes
  • entity Emerging Growth Company false
  • entity File Number 001-39781
  • entity Filer Category Large Accelerated Filer
  • entity Incorporation State Country Code A1
  • entity Interactive Data Current Yes
  • entity Name AbCellera Biologics Inc.
  • entity Registrant Name AbCellera Biologics Inc.
  • entity Shell Company false
  • entity Small Business false
  • income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest --48,148,000
  • income Tax Expense Benefit --8,038,000
  • increase Decrease In Other Operating Assets 6,063,000
  • irs Number 0
  • liabilities 289,419,000
  • liabilities And Stockholders Equity 1,497,919,000
  • liabilities Current 89,591,000
  • liabilities Noncurrent 199,828,000
  • local Phone Number 559-9005
  • net Cash Provided By Used In Financing Activities --458,000
  • net Cash Provided By Used In Investing Activities --149,609,000
  • net Cash Provided By Used In Operating Activities --44,063,000
  • net Income Loss --40,110,000
  • nonoperating Income Expense 16,726,000
  • operating Expenses 77,066,000
  • operating Income Loss --64,874,000
  • operating Lease Liability Current 5,868,000
  • operating Lease Liability Noncurrent 77,265,000
  • other Assets Current 99,155,000
  • other Assets Noncurrent 89,845,000
  • other Liabilities Noncurrent 2,962,000
  • other Noncash Income Expense 3,634,000
  • other Nonoperating Income Expense 3,593,000
  • payments To Acquire Property Plant And Equipment 14,984,000
  • period End 1,680,220,800,000
  • period Start 1,672,531,200,000
  • property Plant And Equipment Gross 254,520,000
  • property Plant And Equipment Net 233,187,000
  • report Link https://www.sec.gov/Archives/edgar/data/1703057/000170305723000008/abcl-20230331_htm.xml
  • research And Development Expense 52,647,000
  • retained Earnings Accumulated Deficit 386,075,000
  • revenue From Contract With Customer Excluding Assessed Tax 12,192,000
  • share Based Compensation 15,474,000
  • stockholders Equity 1,208,500,000
  • trading Symbol ABCL
  • update 1970-01-01
  • weighted Average Number Of Diluted Shares Outstanding 287,767,136
  • weighted Average Number Of Shares Outstanding Basic 287,767,136
  • id REPORTED_FINANCIALS
  • key ABCL
  • subkey 10-Q
  • date 2023-05-04
  • updated 2023-05-05

Related News

Coreaweave at $89 With a $99.4B Backlog and $30B Raised in Seven Months

Coreaweave at $89 With a $99.4B Backlog and $30B Raised in Seven Months

Itai Smidt 11.08.26
Stocks CRWV GOOGL MSFT AMZN
QUBT at $8.83 With a $690M Enterprise Value and a $42.5M Backlog

QUBT at $8.83 With a $690M Enterprise Value and a $42.5M Backlog

Itai Smidt 11.08.26
Stocks QUBT IONQ RGTI QBTS
S&P 500 Holds 7,753 Below Record as Brent Hits $88.89 and the 10-Year Reaches 4.726% Before July CPI

S&P 500 Holds 7,753 Below Record as Brent Hits $88.89 and the 10-Year Reaches 4.726% Before July CPI

Itai Smidt 11.08.26
Stocks Markets NVDA INTC ACHR ABCL
A Boring Dividend Fund Owned 19.3% Energy When Hormuz Closed — Then the Index Cut It by 8 Points

A Boring Dividend Fund Owned 19.3% Energy When Hormuz Closed — Then the Index Cut It by 8 Points

Itai Smidt 10.08.26
Stocks Markets KO CVX PG HD
Stillwater Will Make 1,200 Tonnes by 2027 — China Made 16,001 in One Quarter and Owns 94% of Magnets

Stillwater Will Make 1,200 Tonnes by 2027 — China Made 16,001 in One Quarter and Owns 94% of Magnets

Itai Smidt 10.08.26
Stocks USAR MP CRML MU
Intel Sold $15B of Stock at a 175% Gain and the Anchor Foundry Customer Still Has No Name

Intel Sold $15B of Stock at a 175% Gain and the Anchor Foundry Customer Still Has No Name

Itai Smidt 10.08.26
Stocks INTC MU NVDA AMD
Trade Now
© Trading News. All Rights Reserved Since 2022